Systemic thrombolysis and endovascular thrombectomy in severe acute ischemic stroke after dabigatran reversal with idarucizumab
Quentin Binet(Cliniques Universitaires Saint-Luc), Cédric Hermans(Cliniques Universitaires Saint-Luc), Olivia Rocrelle(Cliniques Universitaires Saint-Luc), André Peeters(Cliniques Universitaires Saint-Luc), Christophe Scavée(Cliniques Universitaires Saint-Luc), Frank Hammer(Cliniques Universitaires Saint-Luc)
Cited by 6
Related Papers
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutations
|Human Mutation|2008|429
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
|Stroke|2020|100
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke
|JAMA Neurology|2020|44
Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?
|Acta gastro-enterologica belgica|2022|31
Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature
|Case Reports in Hematology|2017|29